S

SK bioscience
A302440

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
₩3.15T
EV
₩2.61T
Shares Outstanding
78.35M
Beta
1.18

Wall Street View

Analyst Rating
UNDERPERFORM
Analyst Target Price
₩44000.00
P/E 2025E
-
P/Revenue 2025E
4.76x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About SK bioscience Co.,Ltd.

gainify

S

SK bioscience Co.,Ltd.

A302440

SK bioscience Co.,Ltd. engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally. Its product portfolio includes Skycellflu, a cell cultured influenza surface antigen vaccine; Skycellflu 4-ga ...

Sector

Healthcare

Industry

Biotechnology

CEO

Ahn, Jae-Yong

Employees

984

IPO Date

2021-03-18

Headquarters

310, Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13494, South Korea

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved